They confirmed these findings in vivo, demonstrating that a JAK2 inhibitor depleted the stroma and resulted in densely packed ductal tumor cells with decreased PSC activation, as well as diminished and altered collagen structures [33]. Here, JAK2 is linked to neoplasm.